Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
OKG Capital
London, United Kingdom
- Ownership
- Private
- Development stage
- Other
01
Overview
OKG Capital operates as an active VC investor in early-stage and clinical-stage companies in life sciences, with recent investments supporting progression to clinical development, such as iQure Pharma’s IND-enabling studies and planned Phase 1 trials for CNS therapeutics.
- Therapeutic areas
- OncologyNeurologyInfectious Diseases
- Modalities
- Not applicable directly for OKG Capital as an investor
- Industry
- Investors
02
Partnerships
Collaborations with pharmaceutical companiesclinical networkscharitable foundations
Beyond the preview
Go deeper on OKG Capital.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on OKG Capital.